|
|
||||||||
mediates induction of hepatic type 1 plasminogen
activator inhibitor in response to local tissue injury
1 Department of Nutrition and Physiology, Nihon University College of Bioresource Sciences, Tokyo 154-8516, Japan; 2 Departments of Human Genetics and Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0618; and 3 Department of Pharmacology, Merck Research Laboratories, Merck & Company, Rahway, New Jersey 07065
Type 1 plasminogen activator inhibitor (PAI-1),
a major physiological inhibitor of plasminogen activation, is an
important component of the hepatic acute phase response. We studied the acute phase regulation of murine hepatic PAI-1 in response to systemic
toxicity and local tissue injury in both wild-type mice and in mice in
which the interleukin (IL)-1
gene had been inactivated by gene
targeting. Endotoxin induced plasma PAI-1 antigen levels and PAI-1 mRNA
accumulation in liver to the same extent in both wild-type and
IL-1
-deficient mice. In contrast, turpentine increased plasma PAI-1
and hepatic PAI-1 mRNA accumulation in wild-type mice but not in
IL-1
-deficient mice. Intraperitoneal injection of murine IL-1
rapidly increased plasma PAI-1 and hepatic PAI-1 mRNA in both wild-type
and IL-1
-deficient mice. These results suggest that IL-1
is a
critical inducer of hepatic PAI-1 gene expression during the acute
phase response to local tissue injury. In situ hybridization studies
revealed that hepatocytes are the cells primarily responsible for the
hepatic expression of the PAI-1 gene induced by lipopolysaccharide and turpentine.
gene inactivation; knockout; mouse; acute phase response; turpentine; in situ hybridization
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |